Sbi Securities Co., Ltd. Dyne Therapeutics, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 19 shares of DYN stock, worth $297. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19Holding current value
$297% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DYN
# of Institutions
208Shares Held
102MCall Options Held
234KPut Options Held
238K-
Atlas Venture Life Science Advisors, LLC8.02MShares$126 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$116 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.86MShares$108 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.82MShares$107 Million3.9% of portfolio
-
Janus Henderson Group PLC London, X06.81MShares$107 Million0.13% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $812M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...